Filing Details
- Accession Number:
- 0001209191-23-049778
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-18 16:59:19
- Reporting Period:
- 2023-09-14
- Accepted Time:
- 2023-09-18 16:59:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1816736 | Disc Medicine Inc. | IRON | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1628098 | Atlas Venture Fund X, L.p. | 300 Technology Square, 8Th Floor Cambridge MA 02139 | No | No | Yes | No | |
1742765 | Atlas Venture Associates X, Llc | 300 Technology Square, 8Th Floor Cambridge MA 02139 | No | No | Yes | No | |
1742766 | Atlas Venture Associates X, L.p. | 300 Technology Square, 8Th Floor Cambridge MA 02139 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-09-14 | 94,440 | $53.05 | 1,856,794 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-09-15 | 260,894 | $53.16 | 1,595,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-09-16 | 2,115 | $53.22 | 1,593,785 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4).
- These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.60 inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.05 to $53.365 inclusive.